Nearly 1 in 3 cancer surgeries leave cells behind, doubling the rate that cancer returns. InSyte Bio’s mission is to eliminate the recurrence by ensuring removal of all cancer cells during surgery. We have developed a surgical imaging system that can detect cancer cells 10,000 times more precisely than existing solutions in real-time, during surgery, enabling surgeons and oncologists to effectively combat the spread of cancer. The key to our approach is an ultra-miniaturized molecular imager directly integrated into virtually any surgical instrument - transforming the instrument itself into robotic instruments - into a highly sensitive imager seamlessly operating in the complex, small minimally invasive cavities common to modern cancer surgeries.
Company Details
- Employees
- 4
- Founded
- 2023
- Address
- San Francisco, California 94158, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://insyte.bio
- Keywords
- biotechnology, imaging, intraoperative imaging, cancer, cancer surgery, integrated circuits, optics.
- HQ
- San Francisco, California
Insyte Bio Questions
Insyte Bio's website is https://insyte.bio
Insyte Bio's LinkedIn profile is https://www.linkedin.com/company/insytebio
Insyte Bio has
4 employees.
View email and phone details for 4
employees at Insyte Bio.
Insyte Bio's industry is
Biotechnology Research
Insyte Bio's top competitors are
Zoox,
Perplexity,
Renesas Electronics,
Mytra,
Insyte Inc,
Sapear Inc,
Tempo Sense,
Irhythm Technologies, Inc.,
Samsung Semiconductor,
Tenstorrent.
Insyte Bio's categories are Biotechnology Research
Insyte Bio's founding year is 2023
